Back to Treatments

Treatment

Exagamglogene autotemcel (Casgevy)

1
Conditions
7
Trials
150
Participants
25%
Average Safety

Condition Evidence

Sickle cell disorders

7 trials · 150 participants

93% effectiveness · 25% safety
Exagamglogene autotemcel (Casgevy) | DFDA